Browsed by
Month: January 2022

5 Questions with Chris Sarlo, Founder and Wealth Consultant at Life Science Wealth

5 Questions with Chris Sarlo, Founder and Wealth Consultant at Life Science Wealth

“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people to share a little about themselves, their work, and maybe something completely unrelated. For our first feature of 2022 we welcome Chris Sarlo, Founder and Wealth Consultant at Life Science Wealth...  Read more

Senseonics Announces Business Updates

Senseonics Announces Business Updates

January 4, 2022 – GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced operational and financial business updates. ...  Read more

GRAVITAS THERAPEUTICS APPOINTS BILL ENRIGHT, CEO OF VACCITECH, TO ITS BOARD OF DIRECTORS

GRAVITAS THERAPEUTICS APPOINTS BILL ENRIGHT, CEO OF VACCITECH, TO ITS BOARD OF DIRECTORS

SAN DIEGO, CALIFORNIA, UNITED STATES, January 4, 2022 /EINPresswire.com/ — Gravitas Therapeutics, Inc. (“Gravitas”), a clinical-stage biopharmaceutical company engaged in the development of GR-2397 (previously VL-2397, ASP2397), a novel first-in-class antifungal agent for the treatment of immunocompromised patients with serious fungal infections, today announced the appointment of Bill Enright, CEO of Vaccitech, plc (NASDAQ: VACC; “Vaccitech”), as an independent director to its Board of Directors. In December 2021 Gravitas announced the purchase of GR-2397. ...  Read more

Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022

Catalent Announces Plan for Alessandro Maselli to Become New CEO Effective July 1, 2022

SOMERSET, N.J. – January 5, 2022 — Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, as well as consumer health products, today announced that its Board of Directors has appointed Alessandro Maselli, currently President and Chief Operating Officer, as the company’s next President and Chief Executive Officer, effective July 1, 2022. Maselli will also join the company’s Board of Directors upon assuming his new role. Current Chair and Chief Executive Officer John Chiminski will remain in his present role until July 1, 2022, when he will assume the position of Executive Chair of the Board. ...  Read more

FITCI Value Proposition Class

FITCI Value Proposition Class

What’s your “value proposition?” If you are a business leader, understanding your unique value proposition can help shape your brand identity and inform effective marketing strategies. It’s an essential step in creating a business model that starts with a clear, well-researched statement of what sets your product or service apart from the competition, from a target customer’s perspective. ...  Read more